Genes encoding proteins that regulate chromatin structure and DNA modifications [i.e., chromatin regulatory factors (CRF)] and genes encoding histone proteins harbor recurrent mutations in most human cancers. These mutations lead to modifications in tumor chromatin and DNA structure and an altered epigenetic state that contribute to tumorigenesis. Mutated CRFs have now been identified in most types of cancer and are increasingly regarded as novel therapeutic targets. In this review, we discuss DNA alterations in CRFs and how these influence tumor chromatin structure and function, which in turn leads to tumorigenesis. We also discuss the clinical implications and review concepts of targeted treatments for these mutations. Continued research on CRF mutations will be critical for our future understanding of cancer biology and the development and implementation of novel cancer therapies. Cancer Res; 77(2); 1–7. ©2017 AACR.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2im0P4a
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Is it feasible to develop an artificial intelligence algorithm that can actually... Read more on AuntMinnieEurope.com Related Reading: ...
-
Posttraumatic radioulnar synostosis (RUS) is a rare event following forearm fractures. Consequences are disabling for patients who suffer fr...
-
Security. Let's face it. Software has holes. And hackers love to exploit them. New vulnerabilities appear almost daily. If you have soft...
-
Abstract Salivary gland tumors are rare, comprising less than 3% of all neoplasia of head and neck region. Pleomorphic adenoma is the most ...
-
Cone beam computerized tomography (CBCT) has been widely used in dental implanting. However, the local hospitals usually don’t have access t...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2urgQN9 via IFTTT
-
Abstract Objectives The aim of this prospective cohort study was to determine the effects of rapid maxillary expansion (RME) on the firs...
-
Abstract Patients with locally advanced rectal cancer (LARC) are at tremendous risk of metastatic diseases. To improve the prognoses of LA...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου